| ISA | ALKYLATING-DRUG |
| ANCESTORS | ALKYLATING-DRUG ALL ANTINEOPLASTIC-AGENT DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| ifosfamide | definition: alkylating anticancer drug used in the treatment treatment of non-Hodgkin's lymphoma, sarcoma, melanoma, acute lymphocytic leukemia, and cancer of the ovary, pancreas and lung. Possible side effects are myelosuppression, nausea and vomiting, alopecia and cystitis. Intravenous administration. (en) number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): i_ifosmi.txt origination date: 28/05/2002 |
| Ifex | definition: See ifosfamide (en) term type: synonym part of speech: noun number: mass reliability code: 10 context (x): i_ifex.txt origination date: 28/05/2002 |
| IFF | definition: See ifosfamide (en) term type: acronym part of speech: noun number: mass reliability code: 10 context (x): i_iff.txt origination date: 28/05/2002 |
| ifosfamida | definition: fármaco alquilante antineoplásico, utilizado para el tratamiento del linfoma no- Hodgkin, sarcoma, melanoma, leucemia linfocítica aguda y cáncer de ovario, páncreas y pulmón. Los efectos secundarios más comunes son mielosupresión, nauseas y vómitos, alopecia y cistitis. Administración intravenosa. (es) gender: feminine number: mass part of speech: noun reliability code: 10 term type: main entry term context (x): e_ifosmi.txt origination date: 27/05/2002 |
| Tronoxal | definition: Ver ifosfamida (es) term type: synonym reliability code: 10 part of speech: noun number: mass gender: masculine context (x): e_tronox.txt origination date: 27/05/2002 |